Type 2 diabetes mellitus and heart failure: a scientific statement from the American Heart Association and the Heart Failure Society of America: this statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update

Dunlay, Shannon M., Givertz, Michael M., Aguilar, David, Allen, Larry A., Chan, Michael, Desai, Akshay S., Deswal, Anita, Dickson, Victoria Vaughan +6 more·2019·Circulation
DOI 10.1161/cir.0000000000000691

Cited by (649)

Items 401–500 of 649

  1. Diuretic Combination Therapy in Acute Heart Failure: An Updated Review
    Alessandro Villaschi, Marta Pellegrino, Gianluigi Condorelli, Mauro Chiarito · 2024 · Current Pharmaceutical Design
  2. Incretin-mediated control of cardiac energy metabolism
    Jordan S. F. Chan, Tanin Shafaati, John R. Ussher · 2024 · Journal of Endocrinology
  3. Adult mortality from non-communicable diseases in Fiji's major ethnic groups 2013–17
    Catherine Dearie, Christine Linhart, Carah Figueroa, Varanisese Saumaka, Timothy Dobbins, Stephen L. Morrell, Richard J. Taylor · 2024 · Global Epidemiology
  4. Management of a Dual Low Sodium and Diabetic Diet by Patient-Caregiver Dyads: A Qualitative Descriptive Study
    Leigh Anne DeNotto, Misook Lee Chung, Kaitlin Voigts Key, Gia Mudd‐Martin · 2024 · The Science of Diabetes Self-Management and Care
  5. Comorbid Diabetes Is Associated With Dyspnea Severity and Cardiometabolic Biomarkers in Black Adults With Heart Failure
    Brittany Butts, Joseph A Kamara, Alanna A. Morris, Erica N. Davis, Melinda Kay Higgins, Sandra Barker Dunbar · 2024 · Nursing Research
  6. Chronic Heart Failure: Focus on Differences Between Men and Women
    М. Г. Глезер · 2024 · Kardiologiia
  7. Type 2 diabetes mellitus’ impact on heart failure patients’ exercise tolerance: a focus on maximal fat oxidation during exercise
    Huiying Zhu, Jianchao Pan, Jianxuan Wen, Xiaojing Dang, Xiankun Chen, Yunxiang Fan, Weihui Lu, Wei Jiang · 2025 · Frontiers in Cardiovascular Medicine
  8. Management of diabetes in patients hospitalized for acute cardiac events: Joint position paper from the French Society of Cardiology and the French-speaking Diabetes Society
    Patrick Henry, Sophie Jacqueminet, Gilles Lemesle, Gaëtan Prévost, Boccara, Emmanuel Cosson, Étienne Puymirat, Denis Angoulvant, François Roubille, Serge Kownator et al. · 2025 · Archives of cardiovascular diseases
  9. The relationship of glycosylated hemoglobin A1c and Apolipoprotein A‑1 ratio on short-term prognosis in STEMI patients following PCI: a retrospective study
    Dani Li, Yuyu Sun, Jie Han, Chen Guo, Linying Xia, Jia‐Hao Dou, Wei Jiang, Jie Deng, Jin jia Wei · 2025 · Scientific Reports
  10. Pharmacological treatment patterns and outcomes according to the coexistence of heart failure and Type 2 diabetes: data from the Swedish Heart Failure Registry and National Diabetes Registry
    Francesca Musella, Giulia Ferrannini, Lina Benson, Soffia Guðbjörnsdóttir, Federica Guidetti, Marco Boccalatte, Gerolamo Sibilio, Nicola Orsini, Sandra Eloranta, Carin Corovic Cabrera et al. · 2025 · European Journal of Preventive Cardiology
  11. Insulin-like growth factors and their binding proteins in the heart in rats in experimental diabetes mellitus, growing Guerin’s carcinoma and under their combination
    Elena Mikhaylovna Frantsiyants, Valeriya Akhtyamovna Bandovkina, Irina Viktorovna Kaplieva, Ekaterina Igorevna Surikova, Natal'ya Dmitrievna Cheryarina, Alla Ivanovna Shikhlyarova, Irina Valer'evna Neskubina, Y.A. Pogorelova, Lidiya Konstantinovna Trepitaki, Irina Aleksandrovna Goroshinskaya et al. · 2021 · Cardiometry
  12. Introduction and Basic Concepts in Stem Cell Research and Therapy: The Facts and the Hype
    Mohamed Essawy, Shaimaa Shouman, Shireen Magdy, Ahmed Abdelfattah‐Hassan, Nagwa El‐Badri · 2020 · Learning materials in biosciences
  13. Diabetes and Heart Failure
    E. Rhee · 2021 · Journal of Korean Diabetes
  14. Association Between Tooth Loss and Longitudinal Changes in B-Type Natriuretic Peptide Over 5 Years in Postmenopausal Women: The Nagahama Study
    Shizuko Fukuhara, Keita Asai, Takehisa Fukuhara, A. Kakeno, Shigeki Yamanaka, Kazumasa Nakao, Takuma Watanabe, Katsu Takahashi, Tōru Yamazaki, Chisa Umebachi et al. · 2021 · Current Problems in Cardiology
  15. The prevalence of chronic heart failure and risks stratification of early post-hospital letality (review)
    Pavel A. Aleshechkin, E.V. Shchukina Shchukina, I. Tsiba, Alexander S. Shevchenko, В. В. Василенко, Alexander I. Shulik · 2021 · Актуальные проблемы медицины
  16. Review of non-insulin antidiabetic pharmacotherapy in patients with heart failure diabetes mellitus in the Czech Republic in 2018
    Marek Vícha, Tomáš Skála, Klára Benešová, Ladislav Dušek, Jakub Flašík, Luděk Pavlů, Štěpán Hudec, Miloš Táborský · 2022 · Cor et Vasa
  17. Two‐year trends from the LANDMARC study: A 3‐year, pan‐India, prospective, longitudinal study on the management and real‐world outcome in patients with type 2 diabetes mellitus
    Ashok Kumar Das, Sanjay Kalra, Shashank Joshi, Ambrish Mithal, Prasanna Kumar K. M., AG Unnikrishnan, Hemant P Thacker, Bipin Kumar Sethi, Subhankar Chowdhury, Amarnath Sugumaran et al. · 2023 · Endocrinology Diabetes & Metabolism
  18. Real-World Evidence Supports Higher Prevalence of Heart Failure Among Persons With Type 1 and Type 2 Diabetes Compared With the General Population
    Valerie Garrett, Saurabh Gombar, Jingtong Kaya Huang, Andrea M. Yeung, David Charles Klonoff · 2023 · Journal of Diabetes Science and Technology
  19. The characteristics of heart failure in patients with diabetes mellitus in Sanglah Hospital Denpasar
    Anak Agung Ketut Yunita Paramita, Made Ratna Saraswati, Nyoman Wiryawan · 2021 · Jurnal Penyakit Dalam Udayana
  20. Complex Association Among Diet Styles, Sleep Patterns, and Obesity in Patients with Diabetes
    Yi Zhang, Yanlei Wang, Shengwu Zhang, Yulin Zhang, Qiu Zhang · 2023 · Diabetes Metabolic Syndrome and Obesity
  21. Management of Heart Failure in Patients With Diabetes Mellitus in the UAE: A Call to Action
    Hani Mohamed Sabbour, Aftab Ahmad · 2023 · Journal of Cardiovascular Pharmacology and Therapeutics
  22. Interdisciplinary assessment and diagnostic algorithm: The role of the diabetologist
    Nebojsa M. Lalic · 2021 · Diabetes Research and Clinical Practice
  23. A scoping review of the predictive models of diabetes complications
    Ruth Ndjaboué, Gérard Ngueta, Charlotte Rochefort-Brihay, Sasha Delorme, Daniel Guay, Noah Michael Ivers, Baiju R. Shah, Sharon Elizabeth Straus, Catherine H. Y. Yu, Sandrine Comeau et al. · 2021
  24. Cardiac MRI to guide heart failure and atrial fibrillation drug discovery: a Mendelian randomization analysis
    Amand Floriaan Schmidt, Chris Finan, Mimount Bourfiss, Birgitta K. Velthuis, Esther Puyol Anton, Abdulrahman I. Alasiri, Bram Ruijsink, Folkert Wouter Asselbergs, Anneline S.J.M. te Riele, Jessica van Setten · 2023 · Research Square
  25. Modulating Cardiac Energetics in Cardio-Metabolic Syndromes: A mechanistic, hyperpolarized MR Trial of Ninerafaxstat Treatment
    Moritz Hundertmark, Adrienne. G. Siu, Violet Matthews, Andrew Lewis, James T. Grist, Jai Patel, Paul Chamberlin, Rizwan Sarwar, Arash Yavari, Hakim‐Moulay Dehbi et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  26. Exploring the Barriers and Enablers to Implementing a 16-Week Low-Carbohydrate Diet for Patients With Diabetic Cardiomyopathy
    Sabine Kleissl-Muir, Andrea L Driscoll, Alice J. Owen, Caryn Zinn, Bodil Rasmussen · 2023 · The Journal of Cardiovascular Nursing
  27. Early Identification and Management of Heart Failure in Patients with Diabetes Mellitus in The United Arab Emirates: A Call to Action
    Firas J. Al Badarin, Lina Yasine, Rabih A. Hijazi, Susan Abu Khalaf, Wael A. Almahmeed, Yosef Manla, Feras M. Bader · 2023 · Journal of the Saudi Heart Association
  28. Association Between Left Ventricular Strains and Cardiovascular Risk Factors in Type 2 Diabetic Patients: a Controlled Cross-sectional Study
    Trang Nguyễn Nguyên, V. Nguyễn, Le Van Chi · 2023 · Acta Informatica Medica
  29. Beyond Glycemic Control: Mechanistic Insights Into SGLT-2 Inhibitors in Heart Failure Management
    Shreya Garg, Sai Gautham Kanagala, FNU Anamika, Kinna Parikh, Harmanjit Kaur, Nikita Garg, Rohit Jain · 2023 · Cardiology in Review
  30. Potential cardioprotective effect of Vitamin D and sodium-glucose transport protein 2 inhibitor in improving cardiac hypertrophy and fibrosis in Type 2 diabetic rats
    Nyoman Ririn Chandrika Sari, Prayoga Setiawan, I Nyoman Wiryawan, Anak Agung Ayu Dwi Adelia Yasmin, I Gusti Kamasan Nyoman Arijana · 2024 · Journal of Clinical and Translational Research
  31. Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Heart Failure in Patients With Type 2 Diabetes Mellitus: A Systematic Review
    Hala A Abdelhady, Adoum Oumar Abakar, Ravindra Reddy Gangavarapu, Sayed A Mahmud, Anura Manandhar, Ghadeer Sabir, Iana A Malasevskaia · 2024 · Cureus
  32. Dapagliflozin for the treatment of heart failure with reduced ejection fraction in Brazil: a cost-effectiveness analysis
    Márcio Coutinho Xavier Naves, Angélica Amorim Amato, Ivan Ricardo Zimmermann, Henry Maia Peixoto · 2024 · The Lancet Regional Health - Americas
  33. Association between diabetes and heart failure after coronary artery bypass grafting: Danish register-based cohort study
    Benedicte Bay Oxholm Brodersen, Line Tribler Kristiansen, Sidsel le Fevre Karlsen, Jeppe Hauch, Jan Jesper Andreasen, Kristian Hay Kragholm, Maria Lukács Krogager, Lars Køber, Peter Derek Christian Leutscher, Dorte Melgaard et al. · 2025 · Clinical Research in Cardiology
  34. Management of diabetes in patients hospitalized for acute cardiac events: Joint position paper from the French Society of Cardiology and the French-speaking Diabetes Society
    Patrick Henry, Sophie Jacqueminet, Gilles Lemesle, Gaëtan Prévost, Franck Boccara, Emmanuel Cosson, Étienne Puymirat, Denis Angoulvant, François Roubille, Serge Kownator et al. · 2025 · Diabetes & Metabolism
  35. The prognostic value of serum Mg2+ concentration in patients with heart failure and type 2 diabetes mellitus: a retrospective cohort study
    Yangyang Jiang, Jingshu Zhang, Zhichao Jiang, Xiaoyu Liu, Lixin Wang · 2025 · Endocrine
  36. Sidt2 inhibits islet β-cell dedifferentiation by regulating insulin secretion
    Jing Gu, M Qi, Rui-Xi Zhang, Yingying Song, Xing Hu, Haijun Liu, Ya-Ting Zhang, Wen-Xiu Wu, Ya-Jun Wu, Jiahao Xu et al. · 2025 · Journal of Biological Chemistry
  37. Model for End-Stage Liver Disease Excluding INR Is Associated with Poor Prognosis in Elderly Patients with Decompensated Heart Failure
    Michał Jurkiewicz, Wioletta Szczurek, Michał Skrzypek, Jacek Jerzy Jozwiak, Mariusz Gąsior, Bożena Szyguła‐Jurkiewicz · 2025 · Biomedicines
  38. Dapagliflozin vs. Empagliflozin for cardiorenal risk reduction: Real-world paired data and comparative study in Indonesia
    Fonny Cokro, Rani Sauriasari, Dicky L. Tahapary, Heri Setiawan, Christian Tricaesario, Nurul Hidayati, Sidartawan Soegondo · 2025 · F1000Research
  39. The Role of GLP-1 Receptor Agonists in Rheumatic Diseases: Cardioprotective Potentials, Anti-Inflammatory Effects, and Future Emerging Therapeutic Applications
    Mahmoud Hassan Abdelnabi, Nattanicha Chaisrimaneepan, Cristian Castillo‐Rodriguez, Nouran Eshak, Megan M. Sullivan, Ramzi Ibrahim, Hoang Nhat Pham, Juan Farina, Chadi Ayoub, Vivek Nagaraja et al. · 2025 · Current Treatment Options in Cardiovascular Medicine
  40. Coronary heart disease and type 2 diabetes metabolomic signatures in the Middle East
    Mohamed Mokhtar Elshrif, Keivin Isufaj, Ayman Ahmed El-Menyar, Ehsan Ullah, Alka Beotra, Mohammed Al‐Maadheed, Vidya Mohamed‐Ali, Mohamad Saad, Jassim M. S. Al Suwaidi · 2025 · Frontiers in Endocrinology
  41. Comprehensive CMR evaluation including 4D flow-derived E/A vorticity ratio in overweight adults with and without type 2 diabetes mellitus
    Sungho Park, Erin K. Englund, Takashi Fujiwara, Daniel Enge, Michael Schäfer, Jochen Gerstner Saucedo, E. Clark, Layla A. Abushamat, R. Scalzo, Brian Fonseca et al. · 2025 · Cardiovascular Diabetology
  42. Prevention and Management of Heart Failure Associated with Type 2 Diabetics in Rural Australia
    Allen Guy Ross, Utpal Kumar Mondal, Shakeel Mahmood, Feleke Hailemichael Astawesegn, Anayochukwu Edward Anyasodor, M. Mamun Huda, Subash Thapa, Setognal Birara Aychiluhm, Santosh Giri, Md. Ferdous Rahman et al. · 2025 · Journal of Clinical Medicine
  43. Astragaloside IV Ameliorates Diabetic Cardiomyopathy by Suppressing the GNG2/MRAS-ERK Signaling Pathway
    Ying Dong, Yidi Ma, Shi-Jan Liu, Hong-Yan Zhang, Gen Li, Shi Yan, Qiang Fu · 2026 · International Journal of General Medicine
  44. The impact of diabetes on clinical outcomes in patients with pseudonormal left ventricular diastolic filling pattern and preserved ejection fraction
    Seongjin Park, Dong-Gil Kim, JW Kim, Gi Rim Kim, Woo Jae Jeong, Heejin Jeong, Hyun Cho, Kyu‐Yong Ko, Sung Eun Kim, Hyeon Jeong Oh et al. · 2026 · Heart and Vessels
  45. Categorization of chronic pain subtypes and contributing biomarkers in heart failure
    A Smith, Jamie Rausch, Fletcher A. White, Susan M. Perkins, Kelly L. Wierenga, Miyeon Jung, Christele Vorhies, Sean Jessup, Susan J. Pressler · 2026 · European Journal of Cardiovascular Nursing
  46. Prevalence of diabetic cardiomyopathy in low- and middle-income countries: a systematic review protocol
    Afolake Arowolo, lorenzo bennie, Mahmoud Werfalli, R. Johnson, Mark Emmanuel Engel · 2026 · Systematic Reviews
  47. Mitigating Risk of Kidney Dysfunction After Heart Transplantation and Therapeutic Approaches
    Ersilia M. DeFilippis, Richard Kar-Hang Cheng, ELENA M. DONALD, Shannon M. Dunlay, Lorraine S. Evangelista, Forum D. Kamdar, Prateeti Khazanie, Selma F. Mohammed, Ana Rossi, Harriette G.C. Van Spall et al. · 2026 · Circulation Heart Failure
  48. Diabetes increases the risk of heart failure in myocarditis: a propensity-matched nationwide database analysis
    Rayane El-Khoury, Shadi Mahmoud, Soha Roger Dargham, Ziyad Riyad Mahfoud, Amin Jayyousi, Jassim M. S. Al Suwaidi, Charbel Abi Khalil · 2026 · ESC Heart Failure
  49. Validation of the Arabic version of the composite autonomic symptom score 31 questionnaire in diabetic autonomic neuropathy
    Ahmed Sami Alkotami, Asmaa Aboelfath, Aya Zhran, Amro Maher Stino, Ahmed El‐Dokla · 2026 · Neurological Sciences
  50. Performance of prediction models for incident heart failure and heart failure hospitalization in individuals with type 2 diabetes: a systematic review and meta-analysis
    Alexandra Mircescu, William Allan, Mohammad Haris, Ben Hurdus, Anna Helbitz, William Ginks, Jianhua Wu, Naveed A. Sattar, Mark Colquhoun Petrie, Ramzi Ajjan et al. · 2026 · European Journal of Heart Failure
  51. Spironolactone and New-Onset Diabetes in Heart Failure
    Dung Viet Nguyen, Hoai Thi Thu Nguyen · 2026 · JACC Asia
  52. Glycaemic, cardiorenal, and lipid parameters associated with SGLT2 inhibitors use in Indonesian patients with type 2 diabetes: 12-month multicenter real-world study
    Fonny Cokro, Rani Sauriasari, Dicky L. Tahapary, Heri Setiawan, Christian Tricaesario, Nurul Hidayati, William Djauhari, Jimmy Tandradynata, Sidartawan Soegondo · 2026 · PLoS ONE
  53. All-fiber wireless auscultation garment for cardiopulmonary diagnostics
    Qianyi Li, Ziang Li, Xiaoyu Zhang, Hakan Akgün, Swetika Chaturvedi, Hooi Khee Teo, Kamalesh Anbalakan, David Sim, Kenneth Michael Chew Yun Chi, Kee Thai Yeo et al. · 2026 · Nature Cardiovascular Research
  54. Chronic heart failure and diabetes mellitus: two unsuitably matched partners
    Mădălina Andreea Munteanu, Gina Gheorghe, Ana Maria Alexandra Stănescu, Ovidiu Gabriel Bratu, Nicolae Bacalbaşa, Tiberiu Paul Neagu, Camelia Cristina Diaconu · 2020 · Archives of the Balkan Medical Union
  55. An Evidence-Based Review of Diabetes Care: History, Types, Relationship to Cancer and Heart Disease, Co-Morbid Factors, and Preventive Measures
    Umesh Chandra Gupta, Subhas Chandra Gupta, Shayle Sugandh Gupta · 2022 · Current Nutrition & Food Science
  56. Heart failure and cancer: From active exposure to passive adaption
    Yantao Du, Tao Wu · 2022 · Frontiers in Cardiovascular Medicine
  57. The Role of Modifiable and Non-Modifiable Factors in the Development of Right and Left Ventricular Myocardial Dysfunction in High-Risk Patients
    Valery I. Podzolkov, Daria D. Vanina, Покровская Анна Евгеньевна, Natalia A. Dragomiretskaya, В. В. Козлов · 2022 · Kardiologiia
  58. Effect of Glucagon-like Peptide-1 Receptor Agonist on Cardiac Structure and Function in Patients with Heart Failure: A Systematic Review and Meta-analysis
    Xinyu Zhang, Hongyuan Zhang · 2023 · International Journal of Drug Discovery and Pharmacology
  59. Cardiorenal effects of SGLT2 inhibitors: who might benefit?
    EQ Klug, Brian Lindsay Rayner, Megan Wasserfall, Adri Kok, Martin Mpe, Samuel Ruder, NA Mohamed, D Webb · 2023 · Journal of Endocrinology Metabolism and Diabetes of South Africa
  60. Effects of methotrexate, Moringa oleifera, and Andrographis paniculata extracts on the myocardial and aortic tissue of streptozotocin-nicotinamide-induced hyperglycemic rats
    Dimas Bathoro Bagus Pamungkas, Viskasari Pintoko Kalanjati, Abdurachman, Dwi Martha Nur Aditya, Muhammad Husni Fansury Nasution, Maya Rahmayanti Syamhadi · 2023 · Medical Journal of Indonesia
  61. Diabetes mellitus in patients with heart failure and reduced ejection fraction: a post hoc analysis from the WARCEF trial
    Giulio Francesco Romiti, Katarzyna Nabrdalik, Bernadette Corica, Tommaso Bucci, Marco Proietti, Min Qian, Yineng Chen, John L.P. Thompson, Shunichi Homma, Gregory Y.H. Lip et al. · 2024 · Internal and Emergency Medicine
  62. Quality reporting of randomized controlled trials on SGLT2 inhibitors for heart failure: a comprehensive assessment
    YueGuang Yang, ShunWen Yang, YuBo Han, Guoliang Zou, RuiNan Wang, Li Liu · 2024 · Scientific Reports
  63. The features of heart failure of ischemic origin in patients with concomitant atrial fibrillation and diabetes mellitus
    N.M. Kulaiets · 2024 · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
  64. Stronger positive correlation of the left ventricular mass index and extracellular volume fraction with diastolic function in diabetic patients without myocardial infarction
    Hiroyuki Miura, Masahiro Koseki, Seiko Ide, Yasuhide Asaumi, Yoshiaki Morita, Yasutoshi Ohta, Katsunao Tanaka, Takeshi Okada, Takashi Omatsu, Soshiro Ogata et al. · 2024 · International Journal of Cardiology
  65. Positive Correlation between BMI and Left Ventricle and Atrium Inside Diameter Size in Chinese Type 2 Diabetes Patients with Left Ventricular and Atrial Enlargement
    Jie Zhang, Zhenhua Yang, Xiaoxiang Fan, Qiuping Fei, Yingfei Xi · 2024 · Reviews in Cardiovascular Medicine
  66. ProtecT-2-D trial protocol: cardiovascular protection in patients with type 2 diabetes and established heart and/or vascular disease at a cardio-metabolic clinic—a randomized controlled trial
    Katrine Schultz Overgaard, Roda Abdulkadir Mohamed, Thomas Rueskov Andersen, Jess Lambrechtsen, Kenneth Egstrup, Søren Auscher · 2024 · Cardiovascular Diabetology
  67. Dilemmas in Elderly Diabetes and Clinical Practice Involving Traditional Chinese Medicine
    Chongxiang Xue, Ying Chen, Yuntian Bi, Xiaofei Yang, Keyu Chen, Cheng Cai Tang, Xiaolin Tong, Linhua Zhao, Han Wang · 2024 · Pharmaceuticals
  68. Kill two birds with one stone: Hapatologist’s approach to metabolic dysfunction-associated steatotic liver disease and heart failure
    Yusuke Hirao, Clarke Morihara, Tomoki Sempokuya · 2024 · World Journal of Cardiology
  69. Glycemic and nonglycemic effects of pediatric diabetes in cardiovascular health
    Ana Flores, Erika Morales Ubico, Kelly Blacksher, Emily Cleveland, Lien Inman, Ian Singer, Christina Bond, Uzoma Obiaka, Eliana Melissa Perez-Garcia · 2024 · Progress in Pediatric Cardiology
  70. Epidemiological characteristics and risk factors for heart failure in Japanese patients with type 2 diabetes: A retrospective analysis of the J‐DREAMS database
    M. Ohsugi, Daisuke Nitta, Yusuke Naito, Kohjiro Ueki · 2025 · Journal of Diabetes Investigation
  71. Tratamiento de la diabetes en el paciente con insuficiencia cardiaca: Más allá de la hemoglobina glicosilada
    Gilberto A. Castillo, Enrique Morales-Villegas · 2020 · Revista Colombiana de Cardiología
  72. Design and Synthesis of an Aniline Derivative with Biological Activity on Heart Failure
    Garcimarero‐Espino E. Alejandra, Figueroa‐Valverde Lauro, Rosas‐Nexticapa Marcela, López‐Ramos Maria, Díaz-Cedillo Francisco, Mateu‐Armand Virginia, Ortiz‐Ake Yazmin · 2020 · Combinatorial Chemistry & High Throughput Screening
  73. Treatment of Diabetes and Heart Failure
    B. Brochu, Michael C. Y. Chan · 2020 · Springer eBooks
  74. Detection of Early Vascular Atherosclerosis in Type 2 Diabetes Mellitus Using Ultrasound Radiofrequency-Data Technique
    Haijun Dan, Hong Ji, Ya-Qing Zhou, Cai‐Ying Li, Bu‐Lang Gao · 2021 · Journal of Stroke and Cerebrovascular Diseases
  75. Heart failure management; a perspective from diabetes care
    Baruch Itzhak, Philip Home · 2021 · Diabetes Research and Clinical Practice
  76. Outpatient Management of Type 2 Diabetes Mellitus
    Donna Lee, Joel Zonszein · 2022 · Springer eBooks
  77. Precision Medicine Approaches for Management of Type 2 Diabetes
    David Chen, Jordan Fulcher, EMMA S. SCOTT, Alicia Josephine Jenkins · 2022 · Springer eBooks
  78. TREATMENT OPTIMISATION OF HEART FAILURE IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION AND CONCOMITANT TYPE 2 DIABETES MELLITUS
    Yuliia A. Spivak, Maksim Potyazhenko, Nadia O. Lyulka, K. Ye. Vakulenko, Ya. V. Nos · 2022 · World of Medicine and Biology
  79. Using dapagliflozin in patients with heart failure
    LaKeisha G. Williams, Tori Wiley · 2023 · Nursing
  80. An Observational Study to Assess the Predictors of Cardiac Dysfunction in Type 2 Diabetes Patients
    Mudit Chauhan · 2023 · Journal of Advanced Research in Medicine
  81. Focused Updates: SGLT2 Inhibitors in Patients With Heart Failure and/or Chronic Kidney Disease
    Judy W. M. Cheng, Vincent J Colucci, James S. Kalus, Sarah A. Spinler · 2020 · Annals of Pharmacotherapy
  82. Correction for Collider Bias in the Genome-wide Association Study of Diabetes-Related Heart Failure due to Bidirectional Relationship between Heart Failure and Type 2 Diabetes
    Yan V. Sun, Chang Liu, Qin Hui, Jin J. Zhou, J. Michael Gaziano, Peter W.F. Wilson, the Million Veteran Program, Jacob Joseph, Lawrence S. Phillips · 2023 · medRxiv
  83. Blood Pressure as a Key Mediator in the Link Between Type 2 Diabetes and Heart Failure: Insights from Mendelian Randomization
    Zian Yan, Shuangqing Fu, Jinhui Zhang, Jingjing Chen, Lijun Guo, Yicheng Liu, Pingping Huang, Yiyi Mao, Ruina Bai, Xiaochang Ma · 2024 · Research Square
  84. NT-proBNP Thresholds for Early Heart Failure Detection in Asian Patients With Type 2 Diabetes
    Tai‐Shuan Lai, Chia-Ling Tseng, Cho‐Kai Wu, Liang-Ting Chiang, Yong-Chen Chen, Wan-Lun Hsu · 2026 · medRxiv
  85. Cognitive impairment and distal polyneuropathy in a patient with diabetes mellitus in neurological outpatient practice
    O. V. Kosivtsova, M. P. Platov, S. A. Kochetov · 2020 · Neurology neuropsychiatry Psychosomatics
  86. Optimizing Management of Type 2 Diabetes and Its Complications in Patients With Heart Failure
    Christie Schumacher, Elizabeth Van Dril, Kayce M. Shealy, Jennifer D. Goldman · 2020 · Clinical Diabetes
  87. Diabetes e Insuficiencia Cardíaca
    Walter Alarco · 2020 · Archivos Peruanos de Cardiología y Cirugía Cardiovascular
  88. A novel paradigm for heart failure with preserved ejection fraction
    Ilona Cuijpers · 2020
  89. Mesa 2: Insuficiencia cardíaca y diabetes mellitus tipo 2
    Julieta Méndez, Carolina Gómez Martín, Javier Remón, Solange Houssay, Ezequiel Hernán Forte, Silvana Manfredo, Maria Roselli, Matías Ré, Débora Hernández, Marina Margossian et al. · 2020 · Revista de la Sociedad Argentina de Diabetes
  90. Insufficient evidence regarding benefits from sodium-glucose cotransporter-2 inhibitors in heart failure with preserved ejection fraction
    Tatyana Shamliyan, Anna A. Avanesova, Wilbert S. Aronow · 2020 · Vessel Plus
  91. ABCs of Heart Failure (HFpEF) Management: Guide for Nurse Practitioners
    Mohamed Toufic El Hussein, Sarah Blayney · 2020 · The Journal for Nurse Practitioners
  92. Management of patients with neurological complications of diabetes mellitus
    O. V. Kosivtsova, E. N. Chuprina, Igor A. Strokov, M. P. Platov, S. A. Kochetov · 2020 · Meditsinskiy sovet = Medical Council
  93. Use of Population-Based Health Informatics Research to Improve Care for Patients with Cardiovascular Diseases
    Ify R. Mordi, Magalie Guignard‐Duff, Christopher Hall, Jaa Ming New, Chim Choy Lang · 2020 · Diseases
  94. Letter by Tanaka and Node Regarding Article, “Type 2 Diabetes Mellitus and Impact of Heart Failure on Prognosis Compared to Other Cardiovascular Diseases: A Nationwide Study”
    Atsushi Tanaka, Koichi Node · 2021 · Circulation Cardiovascular Quality and Outcomes
  95. How can older adults combat diabetes to achieve a longer and healthier life
    Ying Shang · 2021 · Figshare
  96. Diabetes and Heart Failure
    Eun‐Jung Rhee · 2021 · Cardiovascular Prevention and Pharmacotherapy
  97. TERAPI NUTRISI PADA NEFROPATI DIABETIK, GAGAL JANTUNG KRONIK NYHA III, KARSINOMA SERVIKS, POST OPERASI URS BILATERAL, REPLACE DJ STENT
    Andi Syurma Sari Ismail, Agussalim Bukhari · 2021 · IJCNP (INDONESIAN JOURNAL OF CLINICAL NUTRITION PHYSICIAN)
  98. Role of Sodium-Glucose Cotransporter-2 Inhibitors in Readmissions for Congestive Heart Failure
    Joseph Keryakos, Robert Kranz, Rachel Propst, Jena Rathert, Kelli Semerad · 2021 · Journal of Young Pharmacists
  99. In Reference to “Optimizing Non-cardiac Prescription in a Cardiac Patient”
    Sandip Ghosh · 2021 · Bengal Physician Journal
  100. Assessment of risk factors for the development of arterial hypertension and ischemic cerebrovascular events (review)
    Natalya I. Golovina, Mariya S. Matveenko, Клюшников Николай Игоревич · 2021 · Актуальные проблемы медицины